Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...

Merck CEO Robert Davis spoke about the new state-of-the-art biologics center slated to be based in Wilmington, Delaware that ...

(Reuters) -U.S. drugmaker Merck is investing $1 billion in a new Delaware plant to expand its domestic production as it ...

Germany’s Merck KGaA has agreed to buy SpringWorks Therapeutics, adding the US biotech’s portfolio of cancer and rare disease ...

FRANKFURT (REUTERS) -German healthcare and materials group Merck KGaA said on Monday it struck a deal to acquire U.S. biotech ...

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce ...

Merck (NYSE: MRK) recently announced its first-quarter results, exceeding Wall Street’s expectations for both earnings and revenue. The company reported revenues of $15.53 billion and adjusted ...

She regularly appears on CBS News 24/7 to discuss her reporting. Merck is investing $1 billion to build a U.S. plant in Delaware, in a show of its commitment to domestic manufacturing. The move ...

Seven weeks after opening a new $1 billion vaccine manufacturing facility in North Carolina, Merck has revealed that it is breaking ground on another $1 billion plant—this one in Wilmington ...

Merck KGaA is building up its portfolio and ... Ogsiveo and Gomekli are under regulatory review in Europe. Ogsiveo is expected to receive a European Medicines Agency decision in desmoid tumors ...

About two months after receiving a sizable taxpayer-funded grant, Merck & Co. officially announced it would build its newest manufacturing facility near Elsmere. A groundbreaking ceremony was held ...

Merck estimates the project will create more than 500 full-time roles and about 4,000 construction jobs. CEO of Main Line public company to step down MRA lands $63M in loans to advance former ...